Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles

Bioorganic & Medicinal Chemistry Letters
2005.0

Abstract

A novel series of tyrosine-derived HIV protease inhibitors was synthesized and evaluated for in vitro antiviral activity against wild-type virus and two protease inhibitor-resistant viruses. All of the compounds had wild-type antiviral activities that were similar to or greater than several currently marketed HIV protease inhibitors. In addition, a number of compounds in this series were more potent against the drug-resistant mutant viruses than they were against wild-type virus.

Knowledge Graph

Similar Paper

Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles
Bioorganic & Medicinal Chemistry Letters 2005.0
Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus
Bioorganic & Medicinal Chemistry Letters 2007.0
Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virus
Bioorganic & Medicinal Chemistry Letters 2003.0
Novel inhibitors of HIV protease
Bioorganic & Medicinal Chemistry Letters 2000.0
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus
Bioorganic & Medicinal Chemistry Letters 2005.0
Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2′ side chains
Bioorganic & Medicinal Chemistry Letters 2006.0
Reduction of Peptide Character of HIV Protease Inhibitors That Exhibit Nanomolar Potency against Multidrug Resistant HIV-1 Strains
Journal of Medicinal Chemistry 2003.0
HIV-1 Protease Inhibitors with a Transition-State Mimic Comprising a Tertiary Alcohol: Improved Antiviral Activity in Cells
Journal of Medicinal Chemistry 2010.0
Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors
European Journal of Medicinal Chemistry 2012.0